Harvard's Wyss Institute collaborates with GBS Inc. on eRapid-based COVID-19 diagnostic
E-Mail IMAGE: The Wyss Institute collaborates with GBS Inc., a subsidiary of The iQ Group Global, to combine its electrochemical eRapid sensing technology with the GBS's transistor technology in developing a multiplexed... view more Credit: Wyss Institute at Harvard University (BOSTON) -- The Wyss Institute for Biologically Inspired Engineering at Harvard University and GBS Inc., a subsidiary of The iQ Group Global, announce that they will collaborate to validate and de-risk a specific and sensitive COVID-19 diagnostic that would integrate the Institute's eRapid technology with th...